Events2Join

FDA is approving drugs faster than ever—but is this a good thing?


FDA Drug Approvals Are Faster But Rely On Less Evidence Than ...

FDA Approves Drugs Faster Than Ever But Relies On Weaker Evidence, Researchers Find · Shots - Health News · One-Third Of New Drugs Had Safety ...

FDA is approving drugs faster than ever—but is this a good thing?

The researchers also found those drug approvals are occurring faster than ever before. The median review time for standard drug applications was ...

The FDA Is Approving Drugs Faster, But That May Not Be A Good ...

The report notes, “In the United States, the number of December drug approvals is roughly 80% larger than in any other month. Similar approval ...

Is the FDA approving drugs too fast?

The FDA's critics cite these recalls as evidence that pressure from the pharmaceutical industry and other special interest groups has accelerated the drug ...

FDA increasingly approves drugs without conclusive proof they work

Between 2011 and 2015, the FDA reviewed new drug applications more than 60 days faster on average than did the European Medicines Agency. Europe ...

Accelerated Approval | FDA

Using a surrogate endpoint enabled the FDA to approve these drugs faster. ... In 2012, Congress passed the Food and Drug Administration Safety ...

How Do Drugs Get Approved (and Fast-Tracked) by the FDA?

Every prescribed drug in the U.S. has gone through a rigorous testing process that can take over a decade to complete before the U.S. Food and ...

FDA approving drugs after fewer trials, providing less information to ...

CORVALLIS, Ore. — The U.S. Food and Drug Administration is approving more novel pharmaceutical drugs based on single clinical trials and ...

Fast Track, Breakthrough Therapy, Accelerated Approval, Priority ...

Speeding the availability of drugs that treat serious diseases are in everyone's interest, especially when the drugs are the first available ...

FDA's accelerated drug approvals often lack confirmatory evidence

Stalled confirmatory trials and lax enforcement plague the Food and Drug Administration's accelerated approval pathway for pharmaceuticals ...

FDA Is Not the Problem - Center for American Progress

Drug development and approval processes ... Today, the FDA's approval process is, on average, faster than that of any other major nation. The FDA ...

Is the FDA approving drugs faster than ever? No, as ... - STAT News

With each breathless announcement and triumphant press release, it seems clear that the Food and Drug Administration is approving new drugs at a record pace ...

Delivering New Medicines Without Sacrificing Safety and Efficacy

All drugs approved under the agency's expedited programs are held to the same approval standards as other FDA drug approvals.

5 things to know about the FDA approval process

FDA-approved drugs and vaccines are safe and effective. Science ... drug development can happen more quickly now than ever before. “If ...

New safety risks detected in one-third of FDA-approved drugs

Almost a third of drugs cleared by the Food and Drug Administration pose safety risks that are identified only after their approval, according to a study ...

Accelerated Approval Program - FDA

If the confirmatory trial shows that the drug actually provides a clinical benefit, then the FDA grants traditional approval for the drug. If ...

The FDA Is Basically Approving Everything. Here's The Data To ...

That rate rose to 86% in 2011, partly as some of those rejected drugs reached the market, fell again to 60% in 2013, and in last year rose to 88 ...

Analysis of US Food and Drug Administration new drug and biologic ...

The annual average number of drugs approved through an FDA designation or expedited review increased from 11.3 ± 4.0 (145, 49.0%) in the period ...

Speeding Up the Drug Approval Process—and What That Means for ...

By providing a mechanism for expedited review with the same rigor used for standard review, new drugs can be made accessible, faster, for patients lacking a ...

Fast Track | FDA

More frequent meetings with FDA to discuss the drug's development plan and ensure collection of appropriate data needed to support drug approval.